RxDoctor Payments DataLook up a doctor →

Trystan Crook, DO

Family Medicine · Overland Park, KSNPI 1437146214

Payments from drug & device makers

$14,912in general payments, 2019–2025

Across 953 payments — averaging $15.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • Lilly USA, LLC$1K
  • Novo Nordisk$1K
  • Amgen$965
  • Boehringer Ingelheim$859
  • Pfizer$698
  • plus $7K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)164$2,627
Lilly USA, LLC86$1,465
Novo Nordisk107$1,307
Amgen56$965
Boehringer Ingelheim47$859
Pfizer67$698
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC45$652
AstraZeneca39$618
Merck33$435
Antares Pharma, Inc.22$416
Otsuka America Pharmaceutical, Inc.18$380
Novartis21$303
Teva Pharmaceuticals USA, Inc.18$272
GSK17$242
Takeda Pharmaceuticals U.S.A., Inc.15$236
Abbott12$233
Biohaven Pharmaceutical Holding Company Ltd.15$227
Corium, LLC13$199
Johnson & Johnson13$190
Bayer9$172
Eisai Inc.9$151
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)7$142
Amarin Pharma, Inc.8$142
Sanofi-aventis U.S. LLC8$140
Axsome Therapeutics, Inc.7$134
Astellas Pharma US Inc7$126
Phathom Pharmaceuticals, Inc.8$125
Exeltis, USA Inc.4$95
Hologic Sales And Service, LLC5$92
IBSA Pharma Inc.5$86
Sumitomo Pharma America, Inc.4$84
Cranial Technologies, Inc5$81
Biohaven Pharmaceuticals, Inc.4$78
Clarus Therapeutics Inc.4$75
Currax Pharmaceuticals LLC5$68
Dexcom, Inc.3$51
Biogen2$49
Tolmar, Inc.3$45
Shield Therapeutics Inc2$43
Shire North American Group Inc3$36
Ardelyx, Inc.2$35
Bausch Health US, LLC2$35
Halozyme Inc2$35
Neos Therapeutics, LP2$34
Esperion Therapeutics, Inc.2$33
Braintree Laboratories, Inc.2$32
Forte Bio-pharma LLC2$31
Gilead1$28
Upsher-smith Laboratories LLC1$28
Agile Therapeutics, Inc.1$23
Idorsia Pharmaceuticals US Inc1$22
Ascendis Pharma Endocrinology Inc1$22
Arbor Pharmaceuticals, Inc.1$20
Apria Healthcare LLC1$18
E.r. Squibb & Sons, L.L.C.1$17
Roche Diagnostics Corporation1$17
Genentech USA, Inc.1$17
Valencia Technologies Corporation1$16
Misonix Inc1$15
Corcept Therapeutics1$14

How this compares

$14,912 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$28,783
Medicare patients
119
Services billed
9,502

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →